Evaluation and Management of Elevated Creatine Kinase

Introduction to Diagnostic Approach

The European Society of Cardiology and the American Heart Association recommend a comprehensive diagnostic approach for patients with elevated creatine kinase (CK), including a complete panel of tests such as troponin, renal function, liver profile, electrolytes, complete blood count, and inflammatory markers, to determine the cause and evaluate potential complications 1, 2
The diagnostic approach should be guided by the severity of CK elevation and associated symptoms, with consideration of cardiac, muscular, and renal causes 3, 4

Renal function should be assessed through serum creatinine and estimated glomerular filtration rate (eGFR) measurements, as renal dysfunction can affect CK and troponin interpretation 1
A complete blood count is recommended to evaluate anemia or other hematological disorders 1
Electrolyte measurements, including sodium, potassium, and calcium, should be performed 5
High-sensitivity troponin measurement is recommended to detect myocardial necrosis, with serial measurements if acute coronary syndrome is suspected 1
CK-MB is useful for diagnosing myocardial infarction and reinfarction, especially in patients with chronic kidney disease 2

The following tests should be performed to evaluate for various conditions:

Test	Indication
AChR, anti-striated muscle antibodies, MuSK, and LPR4 antibodies	Myasthenia gravis diagnosis
Nerve conduction studies, repetitive stimulation, and needle EMG	Polyneuropathy and neuromuscular junction disorders evaluation
MRI spine with and without contrast	Compressive lesions and nerve root enhancement evaluation
Troponin, ECG, and echocardiogram	Concomitant myocarditis evaluation
Negative inspiratory force (NIF) and vital capacity (VC) measurements	Respiratory function assessment

A 12-lead electrocardiogram is recommended to detect ischemic changes or arrhythmias 1
An echocardiogram is recommended if cardiac symptoms, abnormal electrocardiogram, or murmurs are present 6
MRI using T1-weighted, T2-weighted, and fat suppression techniques is useful for identifying a muscle site for biopsy and characterizing the pattern of muscle involvement 7

B-type natriuretic peptide (BNP) or N-terminal pro-BNP measurement is recommended if heart failure is suspected 1
Myoglobin measurement is useful in the first 6 hours of cardiac symptoms 8

A detailed review of medications, especially statins, is recommended as they are a common cause of elevated CK 1
Patients with elevated CK should be monitored and managed according to protocols for acute coronary syndrome if troponin is elevated, with serial troponin measurements 1
For patients with CK elevation and impaired renal function, aggressive hydration and avoidance of nephrotoxic agents are recommended to prevent further kidney damage 9

The following medications should be reviewed and stopped if possible:

Medication	Reason
Beta-blockers	Can worsen neuromuscular weakness
IV magnesium	Can worsen neuromuscular weakness
Fluoroquinolones	Can worsen neuromuscular weakness
Aminoglycosides	Can worsen neuromuscular weakness
Macrolide antibiotics	Can worsen neuromuscular weakness

The American Heart Association recommends considering additional tests for cardiovascular risk if CK is elevated 1
Patients with CK < 3 times the normal value should be monitored, while those with CK 3-5 times the normal value should have CK and troponin repeated, and those with CK > 5 times the normal value should have an urgent evaluation with a complete panel and immediate specialized consultation 1
Cardiac troponin measurement should be considered in patients with elevated CK levels, with interpretation caution in patients with chronic kidney disease (CKD) 3, 10

For mild symptoms with mildly elevated CK (<3× normal), monitoring CK levels and considering acetaminophen or NSAIDs for pain relief is recommended 4
For moderate symptoms or CK elevation (3-5× normal), referral to rheumatology or neurology and consideration of prednisone 10-20 mg/day if inflammatory features are present is recommended 4
For severe symptoms or significant CK elevation (>5× normal), urgent referral to a specialist and consideration of prednisone 0.5-1 mg/kg/day if inflammatory myopathy is suspected is recommended 4
Regular monitoring of muscle strength and function, gradual tapering of immunosuppressive medications, and consideration of steroid-sparing agents are crucial for effective management 11, 7
Pyridostigmine and corticosteroids should be initiated for suspected myasthenia gravis, with a starting dose of 30 mg PO three times daily, titrating as needed 4
Engage patients in tasks promoting normal movement patterns and weight-bearing, encourage optimal postural alignment, and employ anxiety management and distraction techniques 12
Early mobilization and rehabilitation, nutritional support, and multi-professional collaboration are essential for optimizing functional outcomes 12

Inclusion body myositis (IBM) typically occurs after age 50 with a male to female ratio of 3:1, characterized by asymmetric or symmetric weakness, selective involvement of quadriceps, forearm flexors, and biceps/triceps, and dysphagia 7
Creatine kinase (CK) levels are often normal or mildly elevated (less than 12 times normal) in IBM patients, with muscle biopsy being the definitive test for IBM 7
The European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) provide classification criteria for idiopathic inflammatory myopathies, including specific features for IBM subclassification 13